Hemodialysis central venous catheters as a source of inflammation and its implications

Seminars in Dialysis

Volumn 21, Issue 5, 2008, Pages 401-404

  Hung, Adriana M ^a,b   Alp Ikizler, T ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CENTRAL VENOUS CATHETERIZATION; CHRONIC KIDNEY FAILURE; HUMAN; INFLAMMATION; INSTRUMENTATION; METABOLISM; RENAL REPLACEMENT THERAPY;

C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CATHETERIZATION, CENTRAL VENOUS; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 53249131121     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00444.x     Document Type: Article

References (44)

1. USRDS : Renal data system. Minneapolis : United States Renal Data System, 2007
2. Lacson E Jr, Lazarus JM, Himmelfarb J, Ikizler TA, Hakim RM : Balancing Fistula First with Catheters Last. Am J Kidney Dis 50 : 379 395, 2007
3. Nascimento MM, Pecoits-Filho R, Qureshi AR, Hayashi SY, Manfro RC, Pachaly MA, Renner L, Stenvinkel P, Lindholm B, Riella MC : The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant 19 : 2803 2809, 2004
4. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM : The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62 : 1524 1538, 2002
5. Yeun JY, Levine RA, Mantadilok V, Kaysen GA : C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 : 469 476, 2000
6. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C : Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55 : 648 658, 1999
7. Hung AM, Pupim LB, Yu C, Shintani A, Siew E, Ayus C, Hakim RM, Ikizler TA : Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization. Hemodial Int 12 : 236 243, 2008
8. Iseki K, Tozawa M, Yoshi S, Fukiyama K : Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14 : 1956 1960, 1999
9. Movilli E, Brunori G, Camerini C, Vizzardi V, Gaggia P, Cassamali S, Scolari F, Parrinello G, Cancarini GC : The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients. Blood Purif 24 : 387 393, 2006
10. Harbord N, Kuntsevich P, Kotanko P, Amerling R, Dubrow A, Feinfeld D, Gruber S, Levin N, Winchester J : Altered cytokine/chemokine (CK/CC) profiles and CRP in hemodialysis subjects (HDs) with hemodialysis catheters (HDC) and fistulae (F). Am Soc Nephrol Abstr Publ 16 : F-PO807, 2007
11. Goldstein SL, Silverstein DM, Ikizler TA, Ayus CJC : Hemodialysis (HD) vascular access (VA) type is a strong determinant of the inflammatory state in maintenance HD patients (Pts). Am Soc Nephrol Abstr Publ 16 : F-PO779, 2007
12. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS : Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58 : 353 362, 2000
13. Foley RN : Cardiac disease in chronic uremia: can it explain the reverse epidemiology of hypertension and survival in dialysis patients? Semin Dial 17 : 275 278, 2004
14. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ : Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291 : 451 459, 2004
15. Zager PG, Nikolic J, Brown RH, Campell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P : "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54 : 561 569, 1998
16. Tripepi G, Mallamaci F, Zoccali C : Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 16 (Suppl. 1 S83 S88, 2005
17. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J : Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 16 : 1449 1455, 2005
18. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK : Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60 : 1443 1451, 2001
19. Ishani A, Collins AJ, Herzog CA, Foley RN : Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 68 : 311 318, 2005
20. Pastan S, Soucie JM, McClellan WM : Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62 : 620 626, 2002
21. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG : Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 15 : 477 486, 2004
22. McCarthy JT, Steckelberg JM : Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc 75 : 1008 1014, 2000
23. Philipneri M, Al-Aly Z, Amin K, Gellens ME, Bastani B : Routine replacement of tunneled, cuffed, hemodialysis catheters eliminates paraspinal/vertebral infections in patients with catheter-associated bacteremia. Am J Nephrol 23 : 202 207, 2003
24. Priest DH, Peacock JE Jr : Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomes. South Med J 98 : 854 862, 2005
25. Abid Q, Price D, Stewart MJ, Kendall S : Septic pulmonary emboli caused by a hemodialysis catheter. Asian Cardiovasc Thorac Ann 10 : 251 253, 2002
26. Dittmer ID, Tomson CR : Pulmonary abscess complicating central venous hemodialysis catheter infection. Clin Nephrol 49 : 66, 1998
27. Suresh V, McGonigle RJ, Rowe PA, Tse WY : Bacterial meningitis - complication from a dialysis catheter. Clin Nephrol 65 : 457 459, 2006
28. Girndt M, Sester M, Sester U, Kaul H, Kohler H : Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 78 : S206 S211, 2001
29. Pesanti EL : Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 15 : 813 832, 2001
30. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD : Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80 : 299 307, 2004
31. Mitch WE, Goldberg AL : Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335 : 1897 1905, 1996
32. Pupim LB, Ikizler TA : Uremic malnutrition: new insights into an old problem. Semin Dial 16 : 224 232, 2003
33. Stenvinkel P, Lindholm B, Heimburger O : Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease. Semin Dial 17 : 505 515, 2004
34. Del Vecchio L, Pozzoni P, Andrulli S, Locatelli F : Inflammation and resistance to treatment with recombinant human erythropoietin. J Ren Nutr 15 : 137 141, 2005
35. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47 : S11 S145, 2006
36. EBPG : Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Section IV. Failure to respond to treatment. Nephrol Dial Transplant 19 : 1029 1346, 2004
37. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD : Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 42 : 761 773, 2003
38. Kwack C, Balakrishnan VS : Managing erythropoietin hyporesponsiveness. Semin Dial 19 : 146 151, 2006
39. Locatelli F, Andrulli S, Memoli B, Maffei C, Del Vecchio L, Aterini S, De Simone W, Mandalari A, Brunori G, Amato M, Cianciaruso B, Zoccali C : Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. Nephrol Dial Transplant 21 : 991 998, 2006
40. MacDougall IC : Hyporesponsiveness to anemia therapy - what are we doing wrong? Perit Dial Int 21 (Suppl. 3 S225 S230, 2001
41. Malyszko J, Malyszko JS, Hryszko T, Pawlak K, Mysliwiec M : Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients? Am J Nephrol 25 : 586 590, 2005
42. Casadevall N : Cellular mechanism of resistance to erythropoietin. Nephrol Dial Transplant 10 (Suppl. 6 27 30, 1995
43. Weiss G, Goodnough LT : Anemia of chronic disease. N Engl J Med 352 : 1011 1023, 2005
44. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T : IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 : 1271 1276, 2004